Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
10/10/24 Stealth Biotherapeutics Elamipretide (Systemic Delivery) for Cardiomyopathy - Dilated Subscribers Only Subscribers Only Subscribers Only
10/9/24 Clearside (CLSD) CLS-AX for Wet Age-Related Macular Degeneration (Wet AMD) (Ophthalmology) Subscribers Only Subscribers Only Subscribers Only
10/8/24 Stealth Biotherapeutics Elamipretide (Systemic Delivery) for Cardiomyopathy - Dilated Subscribers Only Subscribers Only Subscribers Only
10/8/24 Merck (MRK) Keytruda for Head and Neck Cancer Subscribers Only Subscribers Only Subscribers Only
9/27/24 Johnson (JNJ) Darzalex Faspro for Multiple Myeloma (MM) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
09/12/2024 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/30/2024 Subscribers Only Subscribers Only Trial Data - Top-Line Results
10/16/2024 Subscribers Only Subscribers Only Company - Analyst/R&D Update
10/16/2024 Subscribers Only Subscribers Only Trial Data - Updated Results
10/16/2024 Subscribers Only Subscribers Only Trial Data - Updated Results